When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GSK - Kymera Therapeutics: Selective Protein Degradation Second Mover To Watch
GlaxoSmithKline PLC
Kymera Therapeutics is a next-generation targeted protein degradation company working to drug the undruggable genome.
The company's platform has attracted three biopharma deals worth more than $3B.
Kymera is filing three investigational drug applications in 2021 that might create attractive buying opportunities as the hype of the technology meets the reality of clinical development.